CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 1,190,273	$ (97,579)
Adjustments to reconcile net income (loss) to net cash used by operating activities:
Depreciation and amortization	693,990	665,604
Accretion of asset retirement obligation	14,589	5,197
Common stock payable for directors fees	0	84,375
Gain on settlement of Hillgrove advance	0	(113,422)
Gain on forgiveness of Cares Act debt	0	(443,400)
Write down of inventory to net realizable value	409,919	0
Change in fair value of investments	119,298	0
Changes in operating assets and liabilities:
Accounts receivable	(559,000)	(484,093)
Inventories	(182,457)	(83,743)
Prepaid expenses and other current assets	(187,937)	0
IVA receivable and other assets	(605,047)	(30,612)
Accounts payable	(923,490)	(624,028)
Accrued liabilities	530	(64,417)
Export tax assessment payable	0	(1,120,730)
Accrued liabilities - directors and related parties	52,248	(171,016)
Net cash provided (used) by operating activities	22,916	(2,477,864)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from redemption of certificates of deposit	0	210,184
Purchase of investments	(13,500,000)	0
Proceeds from sales of investments	407,149
Purchase of properties, plants and equipment	(592,221)	(616,479)
Net cash used by investing activities	(13,685,072)	(406,295)
CASH FLOWS FROM FINANCING ACTIVITIES:
Change in checks issued and payable	0	(86,685)
Payments on advances from related party	0	(56,416)
Proceeds from issuance of common stock, net of issuance costs	0	23,342,180
Proceeds from exercise of warrants	0	1,790,703
Payments on Hillgrove advances payable	0	1,020,799
Principal paid on notes payable to bank	0	(100,000)
Principal payments of long-term debt	(42,080)	(86,426)
Net cash provided (used) by financing activities	(42,080)	23,782,557
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(13,704,236)	20,898,398
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD	21,420,329	722,377
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD	7,716,093	21,620,775
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Equipment purchased with note payable	161,600	0
Issuance of common stock for directors fees	$ 62,501	$ 110,000